ClinicalTrials.gg
CompletedNCT06778876Updated Sep 16, 2025

Effect of Lavender on Sleep Quality and Insomnia Severity in Patients

An interventional study of lavender sachet group and control group in Insomnia, Psychophysiological, sponsored by Saglik Bilimleri Universitesi Gulhane Tip Fakultesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-09-16.

Sponsored by Saglik Bilimleri Universitesi Gulhane Tip Fakultesi · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Today, psychophysiological insomnia is the most common persistent insomnia. Lavender essential oil is frequently used in the literature as an aromatherapy method to improve sleep quality. Studies have found that lavender improves sleep quality. They also emphasized that more studies are needed in this area. When the relevant literature is reviewed, no studies examining the effects of lavender oil on patients with psychophysiological insomnia were found. In this context, the aim of the study was to evaluate the effect of lavender on sleep quality and insomnia severity in patients with psychophysiological insomnia.

Read the detailed description

Today, psychophysiological insomnia is the most common persistent insomnia. The patient's inability to sleep occurs as a result of repetitive negative thoughts such as the thought that he will have difficulty sleeping before going to bed and/or past experiences involving the bedroom or the night. More effort to sleep causes more wakefulness and more difficulty falling asleep.

Numerous studies have shown that insomnia seriously affects health and quality of life and can cause various problems including memory problems, depression, irritability, cardiovascular and cerebrovascular diseases, etc. Therefore, looking for effective ways to improve sleep quality is important for individual and social health. Today, drug therapy, psychotherapy, physiotherapy and cognitive-behavioral therapy are widely used treatments for insomnia. Recently, more and more studies have found that aromatherapy is one of the non-drug treatments to improve sleep quality. Lavender essential oil appears in the literature as an aromatherapy method frequently used to improve sleep quality.

Studies have found that lavender improves sleep quality. They also emphasized that more studies are needed in this area. When the relevant literature was examined, no studies were found examining the effects of lavender oil on patients with psychophysiological insomnia. In this context, the aim of the study was to evaluate the effect of lavender on sleep quality and insomnia severity in patients with psychophysiological insomnia.

02

Conditions studied

  • Insomnia, Psychophysiological

Keywords

  • insomnia
  • sleep quality
  • Sleepiness
  • Lavender
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's enrollment of 68 is close to the median of 68 across 2,350 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi is the lead sponsor of 66 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older,
  • Being over 65 years old
  • Being diagnosed with psychophysiological insomnia,
  • Knowing Turkish at a level that will allow you to read and understand the survey questions,
  • Accepting to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having a serious physical or cognitive disability that would prevent him/her from answering the survey,
  • Being under the age of 18,
  • Not accepting to participate in the study,
  • Being allergic to lavender,
  • Having a chronic additional disease related to the respiratory system,
  • Having a psychiatric or neurological additional disease,
  • Using medication(s) that may affect sleep,
  • Experiencing a physical activity limitation that causes bedriddenness,
  • Having or contracting a disease that will affect the ability to smell.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
68 participants (actual)

Study arms

  • Active comparator
    lavender sachet group

    The normal procedure applied in the sleep clinic (keeping a sleep diary, sleep hygiene education) will be followed and participants will be asked to sleep with lavender sachets inside their pillows for two weeks.

    Other: lavender sachet group

  • Sham comparator
    Control group

    Participants will follow the normal procedure applied (keeping a sleep diary, sleep hygiene training) in the sleep clinic and no additional intervention will be performed.

    Other: control group

Interventions

  • Otherlavender sachet group

    The normal procedure applied in the sleep clinic (keeping a sleep diary, sleep hygiene education) will be followed and participants will be asked to sleep with lavender sachets inside their pillows for two weeks.

  • Othercontrol group

    Participants will follow the normal procedure applied (keeping a sleep diary, sleep hygiene training) in the sleep clinic and no additional intervention will be performed.

06

What researchers measure

Primary outcomes

  1. The Pittsburgh Sleep Quality Index

    PSQI is a 19-item scale, assessed by self-report (19 items) and spouse/roommate responses (5 items). The scale includes components such as sleep quality, duration, and disturbance, and the total score ranges from 0 to 21; a score greater than 5 indicates poor sleep quality.

    Time frame: two weeks

Secondary outcomes

  1. The Insomnia Severity Index

    ISS is a 7-item self-report scale. The total score obtained from this scale varies between 0 and 28, and a score of 15 and above indicates clinical insomnia.

    Time frame: two weeks

  2. The Epworth Sleepiness Scale

    ESS is a four-point Likert-type scale consisting of 8 items. The score range of this scale is 0 to 24, and a score of 10 and above indicates excessive daytime sleepiness.

    Time frame: two weeks

07

Study locations

1 site
  • University of Health Sciences
    Ankara, Keçiören 06010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06778876
Lead sponsor
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Responsible party
bülent devrim akçay (University of Health Sciences, Saglik Bilimleri Universitesi Gulhane Tip Fakultesi) — Principal investigator
First posted
Jan 16, 2025
Start date
Jan 21, 2025
Primary completion
Jul 21, 2025
Completion
Sep 12, 2025
Last update
Sep 16, 2025

Study contacts

Bülent D. Akçay, Assoc. Prof.
principal investigator · Saglik Bilimleri Universitesi
Mehmet Koçer, MD
principal investigator · Gulhane Training and Research Hospital
Duygu Akçay, Asst.Prof
principal investigator · Ufuk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion